Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 7 days
Any time
Past hour
Past 24 hours
Past 30 days
Most recent
Best match
HealthDay on MSN
4d
FDA Approves Ebglyss for Moderate-to-Severe Atopic Dermatitis
The U.S. Food and Drug Administration has approved Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and ...
The American Journal of Managed Care
6d
FDA Approves Lebrikizumab For Patients Aged 12 and Older With Moderate to Severe Atopic Dermatitis
The FDA has approved lebrikizumab (Ebglyss; Eli Lilly) as a new first-line biologic treatment for patients aged 12 and older ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Alabama mass shooting
Daylight saving time
Ga. suspect's mom indicted
San Francisco homelessness
California plastic bag ban
Robinson loses key staff
CA firefighter held for arson
Former WA governor dies
Donlon's homes searched
Visits US ammunition plant
Drug price challenge revived
Biden hosts 'Quad' summit
Released after guilty plea
ISR raids Al Jazeera office
Sesame Place suit verdict
Boeing defense chief exits
Iran coal mine blast
SC 1st execution in 13 years
J&J unit files for bankruptcy
No. 1 at box office again
Suns broadcaster dies
CA bill to protect kids online
Dolphins legend Morris dies
TN abortion law blocked
Israeli strikes in Lebanon
No govt. shutdown for now
Free COVID-19 tests
Trump to campaign in MI
Economic speech this week
PM Modi visits US
Feedback